H. Ogata

发表

Enantioselective Tissue Distribution of the Basic Drugs Disopyramide, Flecainide and Verapamil in Rats: Role of Plasma Protein and Tissue Phosphatidylserine Binding

K. Hanada, S. Akimoto, K. Mitsui, 1998, Pharmaceutical Research.

Release and absorption characteristics of chlorphenesin carbamate sustained-release formulations: In vitro-in vivo and in vivo dog-human correlations

M. Akimoto, H. Ogata, A. Furuya, 1995 .

PREPARATION CONDITIONS AND EVALUATION OF THE STABILITY OF LIPID VESICLES (LIPOSOMES) USING THE MICROENCAPSULATION TECHNIQUE

H. Ogata, F. Ishii, A. Takamura, 1988 .

Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.

K. Hanada, H. Ogata, Kazuhiko Asari, 2008, European journal of pharmacology.

Mechanism of intestinal absorption of drugs from oil in water emulsions. I.

H. Ogata, S. Muranishi, H. Sezaki, 1972, Chemical & pharmaceutical bulletin.

Mechanism of intestinal absorption of drugs from oil in water emulsions. II. Absorption from oily solutions.

K. Giga, H. Ogata, S. Muranishi, 1972, Chemical & pharmaceutical bulletin.

Evaluation of Bayesian Estimation of Pharmacokinetic Parameters

A. Yafune, K. Mihara, H. Ogata, 2005, Therapeutic drug monitoring.

Application of the NONMEM method to evaluation of the bioavailability of drug products.

N Aoyagi, N Kaniwa, N. Kaniwa, 1990, Journal of pharmaceutical sciences.

Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate.

N. Kaniwa, H. Ogata, N. Aoyagi, 1982, Journal of pharmaceutical sciences.

[Power of test in bioequivalence analysis. The comparison of tests in beagle dogs and humans].

N. Kaniwa, H. Ogata, N. Aoyagi, 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

BIavailability of metronidazole from sugar-coated tablets in humans. I. Effect of gastric acidity and correlation with in vitro dissolution rate

E. Ejima, N. Kaniwa, H. Ogata, 1985 .

New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents.

K. Maebashi, H. Ogata, T. Kurosawa, 2008, The Japanese journal of antibiotics.

[Drug use evaluation of antidyslipidemic agents at a community hospital in Japan].

H. Echizen, H. Ogata, M. Hashiguchi, 2002, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease

H. Echizen, H. Ogata, M. Hashiguchi, 2007, The Annals of pharmacotherapy.

Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions

H. Echizen, H. Ogata, T. Rikihisa, 1999, European Journal of Clinical Pharmacology.

Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients

H. Ogata, A. Yokoyama, K. Masuhara, 1996, Cancer Chemotherapy and Pharmacology.

Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review.

H. Ogata, F. Ishii, K. Yago, 2001, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Biopharmaceutical studies on the clinical inequivalence of two carbutamide tablets.

H. Ogata, A. Ejima, F. Saffar, 1982, Chemical & pharmaceutical bulletin.

Intestinal First-Pass Metabolism of Eperisone in the Rat

K. Hanada, K. Mihara, H. Ogata, 2001, Pharmaceutical Research.

Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms.

H. Echizen, H. Ogata, M. Murata, 2003, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Comparison of stepwise and simultaneous estimations of population pharmacokinetics and pharmacodynamics of TS-943

N. Kato, M. Akimoto, S. Jingu, 2003, European Journal of Drug Metabolism and Pharmacokinetics.

Assessment of gastric acidity of Japanese subjects over the last 15 years.

N. Kaniwa, H. Ogata, S. Kojima, 2001, Biological & pharmaceutical bulletin.

S. Nakamura, K. Hanada, H. Ogata, 2001, Xenobiotica; the fate of foreign compounds in biological systems.

Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure.

T. Sumiyoshi, M. Nagayama, K. Hanada, 2010, Biological & pharmaceutical bulletin.

Risk factors for antituberculous chemotherapy‐induced hepatotoxicity in Japanese pediatric patients

H. Echizen, H. Ogata, M. Hashiguchi, 2002, Clinical pharmacology and therapeutics.

Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography.

K. Hanada, S. Akimoto, K. Mitsui, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Effect of Lamivudine on Uptake of Organic Cations by Rat Renal Brush‐Border and Basolateral Membrane Vesicles

K. Hanada, H. Ogata, T. Takubo, 2000, The Journal of pharmacy and pharmacology.

Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development.

S. Ozawa, Y. Ohno, H. Kumada, 2012, Drug metabolism and pharmacokinetics.

Drug interactions between theophylline and H2-antagonists, roxatidine acetate hydrochloride and cimetidine: pharmacokinetic analysis in rats in vivo.

M. Furuhata, H. Ogata, N. Nagai, 1995, Biological & pharmaceutical bulletin.

Nonlinear pharmacokinetics of aprindine in guinea pigs.

H. Ogata, M. Shimizu, T. Ohota, 2002, Drug metabolism and pharmacokinetics.

[A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].

H. Ogata, M. Hashiguchi, K. Ohno, 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Selective binding of tamsulosin to genetic variants of human alpha1-acid glycoprotein.

K. Hanada, H. Ogata, Naohiro Tochikura, 2007, Biological & pharmaceutical bulletin.

Effect of food on bioavailability of nalidixic acid from uncoated tablets having different dissolution rates.

N. Kaniwa, H. Ogata, N. Aoyagi, 1984, Journal of pharmacobio-dynamics.

Pharmacokinetic and pharmacodynamic analysis of TS‐943, a selective non‐peptide platelet glycoprotein‐IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs

S. Higuchi, M. Akimoto, S. Jingu, 2002, The Journal of pharmacy and pharmacology.

Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits.

N. Kaniwa, H. Ogata, M. Uchiyama, 1992, Journal of pharmaceutical sciences.

Population Pharmacokinetics and Pharmacodynamics of Cisplatin in Patients with Cancer: Analysis with the NONMEM Program

T. Igarashi, H. Ogata, A. Yokoyama, 1998, Journal of clinical pharmacology.

[Study of factors affecting drug extraction during continuous hemofiltration and hemodiafiltration, and the contribution of extraction to systemic clearance].

K. Hanada, H. Ogata, F. Suzuki, 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure.

H. Fung, H. Ogata, A. Kamiya, 1982, Journal of pharmaceutical sciences.

Determination of propranolol enantiomers in human plasma and urine and in rat tissues using chiral stationary-phase liquid chromatography.

H. Ogata, K. Someya, S. Kanno, 1988, Journal of pharmaceutical sciences.

The bioavailabilities of aspirin from an aspirin aluminum and an aspirin tablet and the effects of food and aluminum hydroxide gel.

N. Kaniwa, H. Ogata, N. Aoyagi, 1981, Journal of pharmacobio-dynamics.

[Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].

K. Kushida, K. Hanada, H. Ogata, 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds.

A. Terada, H. Echizen, H. Ogata, 1999, Nutrition.

Stereoselective First-Pass Metabolism of Verapamil in the Small Intestine and Liver in Rats

K. Hanada, K. Mihara, H. Ogata, 2008, Drug Metabolism and Disposition.

Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity

Kazuhiro Hotta, H. Ogata, N. Nagai, 2004, Cancer Chemotherapy and Pharmacology.

Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity.

N. Kaniwa, H. Ogata, N. Aoyagi, 1986, International journal of clinical pharmacology, therapy, and toxicology.

Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteers

N. Kaniwa, H. Ogata, N. Aoyagi, 1986 .

Bioavailability of sugar-coated tablets of thiamine disulfide in humans. I. Effect of gastric acidity and in vivo-in vitro correlation.

K. Kohno, N. Kaniwa, H. Ogata, 1986, Chemical & pharmaceutical bulletin.

Bioavailability of pyridoxal phosphate from enteric-coated tablets. II. Effects of gastric acidity of humans.

N. Kaniwa, H. Ogata, N. Aoyagi, 1985, Chemical & pharmaceutical bulletin.

Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.

N. Kaniwa, H. Ogata, N. Aoyagi, 1985, International journal of clinical pharmacology, therapy, and toxicology.

The bioavailability of diazepam from uncoated tablets in humans--Part II: effect of gastric fluid acidity.

N. Kaniwa, H. Ogata, N. Aoyagi, 1982, International journal of clinical pharmacology, therapy, and toxicology.

Comparison of pharmacokinetics of individual teicoplanin components in patients.

K. Hanada, H. Ogata, Toshimi Kimura, 2007, Biological & pharmaceutical bulletin.

Improved quantitative determination of total and unbound concentrations of six teicoplanin components in human plasma by high performance liquid chromatography.

K. Hanada, H. Ogata, Toshimi Kimura, 2005, Biological & pharmaceutical bulletin.

Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans.

N. Kaniwa, H. Ogata, N. Aoyagi, 1984, Journal of pharmacobio-dynamics.

Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets.

N. Kaniwa, H. Ogata, N. Aoyagi, 1982, Journal of pharmacobio-dynamics.

Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions

H. Ogata, F. Ishii, I. Sasaki, 1990, The Journal of pharmacy and pharmacology.

Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.

N. Kaniwa, H. Ogata, N. Aoyagi, 1984, Journal of pharmacobio-dynamics.

Bioavailability of indomethacin capsules in humans (II): correlation with dissolution rate.

N. Kaniwa, H. Ogata, N. Aoyagi, 1985, International journal of clinical pharmacology, therapy, and toxicology.

Development and evaluation of a new peroral test agent GA-test for assessment of gastric acidity.

N. Kaniwa, H. Ogata, Y. Takagishi, 1984, Journal of pharmacobio-dynamics.

Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats

K. Hanada, H. Ogata, T. Nishimura, 2008, The Journal of pharmacy and pharmacology.

Pharmacokinetics and Toxicodynamics of Oxaliplatin in Rats: Application of a Toxicity Factor to Explain Differences in the Nephrotoxicity and Myelosuppression Induced by Oxaliplatin and the Other Platinum Antitumor Derivatives

K. Hanada, H. Ogata, M. Suda, 2010, Pharmaceutical Research.

Effects of Disopyramide and Verapamil on Renal Disposition and Nephrotoxicity of Cisplatin in Rats

K. Hanada, H. Ogata, K. Odaka, 1999, Pharmaceutical Research.

Effect of Buthionine Sulphoximine, Glutathione and Methimazole on the Renal Disposition of Cisplatin and on Cisplatin‐induced Nephrotoxicity in Rats: Pharmacokinetic‐Toxicodynamic Analysis

K. Hanada, H. Ogata, Y. Mukasa, 2000, The Journal of pharmacy and pharmacology.

Pharmacokinetics and Toxicodynamics of Cisplatin and Its Metabolites in Rats: Relationship between Renal Handling and Nephrotoxicity of Cisplatin

K. Hanada, H. Ogata, Kimie Ninomiya, 2000, The Journal of pharmacy and pharmacology.

Uptake of Cisplatin and its Metabolites Into Rat and Rabbit Renal Cortical Slices

K. Hanada, H. Ogata, N. Nagai, 1998 .

Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo

H. Ogata, N. Nagai, 1997, Cancer Chemotherapy and Pharmacology.

Decomposition Kinetics of Cisplatin in Human Biological Fluids

H. Ogata, N. Nagai, M. Kinoshita, 1996, The Journal of pharmacy and pharmacology.

Quantitative determination of unchanged cisplatin in rat kidney and liver by high-performance liquid chromatography.

K. Hanada, H. Ogata, N. Nagai, 1995, Journal of chromatography. B, Biomedical applications.

Enantioselective Binding of Propranolol, Disopyramide, and Verapamil to Human α1‐Acid Glycoprotein

K. Hanada, H. Ogata, M. Arai, 2000 .

Effect of Trimethoprim on the Renal Clearance of Lamivudine in Rats

K. Hanada, H. Ogata, T. Takubo, 2000, The Journal of pharmacy and pharmacology.

Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits

K. Hanada, H. Ogata, M. Hashiguchi, 2001, The Journal of pharmacy and pharmacology.

Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.

K. Hanada, H. Ogata, Y. Tsukahara, 2001, Biological and Pharmaceutical Bulletin.

Uptake of lamivudine by rat renal brush border membrane vesicles

K. Hanada, H. Ogata, T. Takubo, 2002, The Journal of pharmacy and pharmacology.

Mechanism of the intestinal absorption of drugs from oil in water emulsions. 3. Absorption and biotransformation of methyl orange.

H. Ogata, H. Sezaki, K. Kakemi, 1972, Chemical and pharmaceutical bulletin.

Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.

H. Ogata, K. Masuhara, K. Someya, 1995, International journal of clinical pharmacology research.

Relative bioavailability of two disopyramide capsules in humans based on total, unbound, and unbound enantiomer concentrations

H. Ogata, H. Takahashi, M. Shimizu, 1993, Biopharmaceutics & drug disposition.

Dosing rate-dependent relationship between propranolol plasma concentration and beta-blockade.

H. Ogata, K. Someya, H. Takahashi, 1993, The Journal of pharmacology and experimental therapeutics.

Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans.

H. Ogata, K. Masuhara, K. Someya, 1991, Journal of pharmaceutical sciences.

Binding interaction between enantiomers of disopyramide and mono-N-dealkyldisopyramide on plasma protein.

H. Ogata, H. Takahashi, Y. Seki, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.

H. Ogata, K. Masuhara, H. Takahashi, 1990, Journal of chromatography.

No Effect of High‐Protein Food on the Stereoselective Bioavailability and Pharmacokinetics of Verapamil

A. Urae, S. Irie, H. Ogata, 1996, Journal of clinical pharmacology.

Variability in absorption lag time of pyridoxal phosphate under fasting and pre‐ and post‐meal conditions

H. Ogata, H. Takahashi, N. Nagai, 1994, Biopharmaceutics & drug disposition.

Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography.

T. Sumiyoshi, M. Nagayama, K. Hanada, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Plasma protein binding and blood cell distribution of propranolol enantiomers in rats.

H. Ogata, H. Takahashi, 1990, Biochemical pharmacology.

Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.

H. Ogata, S. Kanno, H. Takahashi, 1990, The Journal of pharmacology and experimental therapeutics.

A population approach to eplerenone pharmacokinetics and saturable protein binding.

H. Ogata, Harumi Takahashi, K. Chiba, 2010, Drug metabolism and pharmacokinetics.

Clinical characteristics influencing the effectiveness of metformin on Japanese type 2 diabetes receiving sulfonylureas.

Y. Tamura, R. Kawamori, H. Watada, 2007, Endocrine journal.

Effects of Indoxylsulfate on the in vitro Hepatic Metabolism of Various Compounds Using Human Liver Microsomes and Hepatocytes

K. Hanada, H. Ogata, K. Son, 2006, Nephron Physiology.

Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer

Y. Okazaki, M. Narabayashi, Y. Ando, 2009, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.

H. Fung, H. Ogata, A. Kamiya, 1984, Journal of pharmaceutical sciences.

Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates.

N. Kaniwa, H. Ogata, N. Aoyagi, 1988, Journal of pharmacobio-dynamics.

Pharmacokinetic study of darbepoetin alfa: Absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats

H. Ogata, S. Kitajima, C. Mitsuoka, 2007, Xenobiotica; the fate of foreign compounds in biological systems.

Use of PKM-MULTI program for fitting discontinuous absorption profiles using a microcomputer.

N. Kaniwa, H. Ogata, N. Aoyagi, 1984, Journal of Pharmacobio-Dynamics.

The spreading of radiolabelled fatty suppository bases in the human rectum

H. Ogata, T. Kogure, M. Noguchi, 1988 .

Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients

S. Ishida, S. Ozawa, Y. Ohno, 2008, Drug Metabolism and Disposition.

Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?

H. Ohmatsu, R. Kakinuma, N. Saijo, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bioavailability and diuretic effect of furosemide during long-term treatment of chronic respiratory failure

H. Ogata, K. Machida, Y. Maruyama, 2004, European Journal of Clinical Pharmacology.

Bioavailability of pyridoxal phosphate from enteric-coated tablets. I. Apparent critical dissolution pH and bioavailability of commercial products in humans.

N. Kaniwa, H. Ogata, H. Kamiyama, 1985, Chemical & pharmaceutical bulletin.

Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution rates.

N. Kaniwa, H. Ogata, H. Kamiyama, 1985, Chemical & pharmaceutical bulletin.

Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.

A. Ohnishi, H. Ogata, M. Ishii, 1996, Biopharmaceutics & drug disposition.

Determination of KRN321 in Rat Serum by ELISA and Correlation Between ELISA and in vitro Bioassay

H. Ogata, E. Yoshioka, Kanako Kato, 2006, Journal of immunoassay & immunochemistry.

Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration.

T. Akizawa, E. Uchida, H. Ogata, 2007, British journal of clinical pharmacology.

Interaction between erythrocytes from various animals and emulsions stabilized with various lecithins.

H. Ogata, F. Ishii, Y. Nagasaka, 1989, Journal of Pharmacy and Science.

Compatibility of Intravenous Fat Emulsions with Prodrug Amino Acids

H. Ogata, F. Ishii, A. Takamura, 1988, The Journal of pharmacy and pharmacology.

Impairment state of cognitive performance and the affecting factors in outpatients following gastrointestinal endoscopy after single-dose diazepam.

Yoshiyuki Watanabe, F. Itoh, H. Ogata, 2005, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Bioavailability of cyclandelate from capsules in beagle dogs and dissolution rate: correlations with bioavailability in humans.

N. Kaniwa, H. Ogata, N. Aoyagi, 1991, Journal of pharmacobio-dynamics.

A Use of Monte Carlo Integration for Population Pharmacokinetics with Multivariate Population Distribution

Akifumi Yafune, A. Yafune, H. Ogata, 1998, Journal of Pharmacokinetics and Biopharmaceutics.

Treatment with midazolam for nocturnal sedation of terminal cancer patients in a hospice setting

K. Hanada, H. Ogata, H. Kouta, 2007 .

Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers

H. Ogata, A. Ejima, Y. Kawatsu, 2004, European Journal of Clinical Pharmacology.

Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.

H. Ogata, K. Someya, H. Takahashi, 1990, Journal of pharmaceutical sciences.

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients

Koujirou Yamamoto, M. Kurabayashi, Katsunori Nakamura, 2006, Clinical pharmacology and therapeutics.

Effi cient dosage regimen for introduction of warfarin treatment after cardiovascular surgery in Japanese patients : comparisons between coronary artery bypass grafting and surgery for valvular heart disease

T. Sumiyoshi, K. Hanada, H. Ogata, 2009 .

Determination of metoclopramide and its glucuronide and sulphate conjugates in human biological fluids (plasma, urine and bile) by ion-pair high-performance liquid chromatography.

T. Ishizaki, H. Echizen, H. Ogata, 1987, Journal of chromatography.

Gastrointestinal transit of non-disintegrating solid formulations in humans

H. Ogata, T. Kogure, M. Noguchi, 1990 .

Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.

N. Kaniwa, H. Ogata, N. Aoyagi, 1988, Journal of pharmacobio-dynamics.

Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet.

H. Ogata, T. Shibazaki, A. Ejima, 1979, Journal of pharmaceutical sciences.

Power analyses of moment analysis parameter in bioequivalence tests.

N. Kaniwa, H. Ogata, M. Uchiyama, 1989, Journal of pharmaceutical sciences.

Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.

H. Ogata, T. Hayashi, N. Aoyagi, 1984, International journal of clinical pharmacology, therapy, and toxicology.

International harmonization of bioequivalence studies and issues shared in common.

H. Ogata, K. Nakai, M. Fujita, 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Evaluation of gastrointestinal transit controlled-beagle dog as a suitable animal model for bioavailability testing of sustained-release acetaminophen dosage form

M. Akimoto, H. Ogata, A. Furuya, 1995 .

Evaluation of beagle dogs as an animal model for bioavailability testing of cinnarizine capsules

N. Kaniwa, H. Ogata, T. Ohki, 1986 .

Bioavailability of metronidazole from sugar-coated tablets in humans. II. Evaluation of beagle dogs as an animal model

N. Kaniwa, H. Ogata, Y. Takagishi, 1985 .

Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.

K. Ohashi, R. Aso, H. Ogata, 1995, International journal of clinical pharmacology research.

Improved high-performance liquid chromatographic analysis of teniposide in human plasma.

K. Mihara, H. Ogata, N. Nagai, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Determination of propranolol and its major metabolite, naphthoxylactic acid, in human plasma by high performance liquid chromatography.

H. Ogata, A. Ejima, H. Takei, 1983, Chemical & pharmaceutical bulletin.

Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.

S. Atagi, K. Hanada, H. Ogata, 2001, Japanese journal of clinical oncology.

[Effectiveness of anti-emetics for the prophylaxis of cisplatin-induced delayed emesis: a systematic review].

K. Mihara, H. Ogata, F. Ishii, 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

シスプラチンによる遅発性悪心•嘔吐に対する薬物療法の検討：システマティック•レビュー

K. Mihara, H. Ogata, F. Ishii, 2004 .

Stereoselective disposition and metabolism of disopyramide in pediatric patients.

K. Chiba, T. Ishizaki, H. Echizen, 1991, The Journal of pharmacology and experimental therapeutics.

Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.

K. Yamashita, H. Nakayama, Y. Sasaki, 2010, Japanese journal of clinical oncology.

Clinical and Economic Evaluation of First-line Therapy with FOLFIRI or Modified FOLFOX 6 for Metastatic Colorectal Cancer

K. Yamashita, H. Nakayama, Y. Sasaki, 2010 .

Bioavailability of sugar-coated tablets of thiamine disulfide in humans. II. Correlation with bioavailability in beagle dogs.

K. Kohno, N. Kaniwa, H. Ogata, 1986, Chemical & pharmaceutical bulletin.

The renal clearance of unchanged cisplatin during furosemide and mannitol diuresis is dependent on glomerular filtration rate in rats.

H. Ogata, N. Nagai, 1996, Journal of pharmaceutical sciences.